Drug details
Saxenda (liraglutide [rdna origin]) injection)
type of Antidiabetics, Glucagon-like Peptide-1 Agonists
Saxenda (liraglutide [rDNA origin]) Injection is an analog of human GLP-1 and acts as a GLP-1 receptor agonist used for as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients with an initial body mass index (BMI) of 30 kg/m2 or greater (obese), or 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbid condition (e.g., hypertension, type 2 diabetes mellitus, or dyslipidemia).
This drug may have the following side effects:
- nausea,
- vomiting,
- diarrhea,
- fever,
- pale skin,
- chills,
- fatigue,
- sweating,
- anxiety,
- irritability,
- hunger,
- depression
- dehydration,
- abdominal pain that increases after eating,
- shakiness,
- upper abdominal pain,
- abdominal pain that radiates to your back,
- yellowing of the skin and eyes (jaundice),
- acute gallbladder disease,
- heart rate increase,
- suicidal behavior, and
The following drugs are related to Saxenda, either as a replacement or used together:
- Adipex-P (phentermine hydrochloride)
- Belviq (lorcaserin hydrochloride)
- Didrex (benzphetamine)
- Contrave (naltrexone hcl and bupropion hcl extended-release tablets)
- Desoxyn (methamphetamine hydrochloride)
- Gvoke (glucagon injection)
- Imcivree (setmelanotide injection, for subcutaneous use)
- Jentadueto XR (linagliptin and metformin hydrochloride extended-release tablets)
- Meridia (sibutramine hydrochloride monohydrate)
- Riomet ER (metformin hydrochloride for extended-release oral suspension)
- Xenical (orlistat 120 mg)
- Qsymia (phentermine and topiramate)
- Suprenza (phentermine hydrochloride)
- Plenity (superabsorbent hydrogel particles in capsules)
- Rybelsus (semaglutide tablets)
- Wegovy (semaglutide injection)